Neurology | Clinical | IPO
Clinical company developing platform of neuromodulators for neurology indications.
Oncology | Preclinical | Active
Preclinical company developing immunotherapy platform for oncology applications.
Oncology | Clinical | Active
Clinical company developing therapeutics for rare brain tumors.
Rare Disease, Neurology, Immunology | Commercial | Active
Commercial company developing gene therapies for rare immunology disorders.
Rare Disease, Immunology | Clinical | Active
Clinical stage company developing therapeutics for rare dermatological disorders.
Rare Disease | Preclinical | Active
Preclinical company developing therapeutics targeting key biological pathways in fibrosis.
Rare Disease, Oncology | Preclinical | Active
Preclinical company developing gene-editing platform for oncology and rare diseases.
Rare Disease, Oncology, Neurology | Preclinical | Active
Preclinical company developing platform to correct RNA expression in neurology, oncology and rare diseases.
Neurology | Preclinical | Active
Preclinical company developing therapies for neurodegenerative diseases.